Do HPV 16 positive/ASC-H cervical cancer screening results predict CIN 2+ better than other high-risk HPV subtypes?
- Abdurrahman Alp Tokalıoğlu 1, Aysun Alcı 2, Okan Oktar 3, Mehmet Ünsal 1, Necim Yalçın 2, Okan Aytekin 1, Fatih Çelik 1, Gülşah Tiryaki Güner 1, Burak Ersak 1, Fatih Kılıç 1, Sevgi Ayhan 1, Serra Akar İnan 1, Caner Çakır 3, Hakan Yalçın 1, Vakkas Korkmaz 3, Sevgi Koç 3, Nurettin Boran 3, Günsu Kimyon Cömert 1, Tayfun Toptaş 2, Işın Üreyen 2, Osman Türkmen 1, Özlem Moraloğlu Tekin 4, Fazlı Erdoğan 5, Yaprak Engin-Üstün 6, Taner Turan 1
- 1Clinic of Gynecologic Oncology, University of Health Sciences Turkey, Ankara City Hospital, Ankara, Turkey.
- 2Clinic of Gynecologic Oncology, University of Health Sciences Turkey, Antalya Training and Research Hospital, Antalya, Turkey.
- 3Clinic of Gynecologic Oncology, University of Health Sciences Turkey, Etlik Zübeyde Hanım Women's Health Training and Research Hospital, Ankara, Turkey.
- 4Clinic of Obstetrics and Gynecology, University of Health Sciences Turkey, Ankara City Hospital, Ankara, Turkey.
- 5Clinic of Pathology, Ankara Yıldırım Beyazıt University, Ankara City Hospital, Ankara, Turkey.
- 6Clinic of Obstetrics and Gynecology, University of Health Sciences Turkey, Etlik Zübeyde Hanım Women's Health Training and Research Hospital, Ankara, Turkey.
- 0Clinic of Gynecologic Oncology, University of Health Sciences Turkey, Ankara City Hospital, Ankara, Turkey.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.High-risk human papillomavirus (HPV) positivity, particularly HPV 16, is significantly correlated with CIN 2+ lesions in patients with ASC-H cytology. This finding highlights the importance of HPV testing in managing ASC-H results for early detection of high-grade dysplasia.
Area Of Science
- Gynecologic Oncology
- Cervical Pathology
- Virology
Background
- Atypical squamous cells, cannot exclude high-grade squamous intraepithelial neoplasia (ASC-H) is a cytologic finding requiring further investigation.
- The role of high-risk human papillomavirus (HPV) testing in managing ASC-H cases requires clarification.
Purpose Of The Study
- To investigate the correlation between high-risk HPV types and the presence of cervical intraepithelial neoplasia grade 2 or higher (CIN 2+) lesions in patients with ASC-H cytology.
Main Methods
- Retrospective analysis of data from 5,271 patients who underwent colposcopy between 2003 and 2021.
- Focus on 163 patients with ASC-H cytology, with 83 HPV-positive cases included.
- Correlation analysis between HPV status (especially HPV 16) and final pathology results (CIN 2+).
Main Results
- No significant correlation was found between patient age and CIN 2+ lesions (p=0.053).
- HPV 16 positivity (alone or with other types) significantly increased the likelihood of CIN 2+ lesions in final pathology.
- The probability of CIN 2+ lesions was 72.5% in HPV 16-positive ASC-H patients versus 48.1% in HPV 16-negative patients (p=0.033).
Conclusions
- Current guidelines lack comprehensive definitions for HPV testing in ASC-H management.
- Positive high-risk HPV results, especially HPV 16, in conjunction with ASC-H cytology, suggest a higher possibility of high-grade dysplasia.
- HPV testing, particularly for HPV 16, is a valuable tool in assessing the risk of significant cervical pathology in ASC-H cases.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

